CIK 0001659617
- Non-accelerated filer
- Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474671997
- Phone
- +1 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 100,000 shares at $1.70 ($170,300)
- 4 Open-market sale 10% owner sold 100,000 shares at $1.70 ($170,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 12,000 shares at $0.81 ($9,720)
- 4 Open-market buy Director bought 1,000 shares at $0.82 ($820)
- 4 Open-market buy Director bought 1,000 shares at $0.94 ($938)
- 4 Open-market buy Exec. Vice President & CFO bought 10,000 shares at $0.86 ($8,649)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 7 of 8 · 143 filings